Kyung Nam Pharm accepts court’s rejection of the largest shareholder’s Request for Preliminary Injunction against New Stock Issuance
As the Request for Preliminary Injunction against New Stock Issuance filed by the largest stockholder Mr. Hee-Cheol Lee against Kyung Nam Pharm, the Kyung Nam Pharm’s conflict between the company and the largest stockholder is facing a new state.
Kyung Nam Pharm gave an official notice on the 18...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
